269 filings
Page 6 of 14
8-K
oee7wyb4ai2sok75f1
21 Feb 19
TherapeuticsMD Announces Fourth Quarter and Full-Year 2018 Financial Results
4:09pm
8-K
6lwnr4buxw6o80uk38kf
4 Feb 19
Investor Update February 4 , 2019
7:00am
8-K
5qn766hpejv1d
9 Jan 19
Regulation FD Disclosure
12:00am
8-K
n7p19
8 Jan 19
Regulation FD Disclosure
7:01am
8-K
8odttu07r c8tkz4io9l
18 Dec 18
Regulation FD Disclosure
6:45am
8-K
i3auhg9bw
27 Nov 18
Regulation FD Disclosure
6:49am
8-K
mnbskm15
13 Nov 18
Regulation FD Disclosure
6:49am
8-K
mzlu2jnw tg
7 Nov 18
TherapeuticsMD Announces Third Quarter 2018 Financial Results
4:08pm
8-K
tj6i8s9mnsrye22zetg
29 Oct 18
Regulation FD Disclosure
6:04am
8-K
phmvnbcs etghzpbdoc
2 Oct 18
Regulation FD Disclosure
7:00am
8-K
ffz2t
27 Sep 18
Regulation FD Disclosure
12:00am
8-K
3l80 6lgz1xv
24 Sep 18
Regulation FD Disclosure
7:00am
8-K
14impvypufsp96ozl w5
5 Sep 18
Regulation FD Disclosure
12:00am
8-K
8y7w54fhti 5mh23j8
21 Aug 18
Regulation FD Disclosure
12:00am
8-K
dfcw4mbn7q
13 Aug 18
TherapeuticsMDAnnounces FDA Approval of ANNOVERA ™(Segesterone Acetate/Ethinyl Estradiol Vaginal System) for Birth Control
6:01am
8-K
31ord
3 Aug 18
Entry into a Material Definitive Agreement
9:28am
8-K
0j5dmavd cq5
30 Jul 18
TherapeuticsMD Announces Second Quarter 2018 Financial Results
12:00am
8-K
brfxf aiwdn45dn55
26 Jun 18
Submission of Matters to a Vote of Security Holders
5:00pm
8-K
4ni0z4i
7 Jun 18
TherapeuticsMD Announces Draw Down of $75 Million Under Term Loan with MidCap Financial
4:05pm
8-K
rihrqmfh pvvv
4 Jun 18
Regulation FD Disclosure
12:00am